Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products recently announced the appointment of Arthur L. Rosenthal to Chairman of its Board of Directors.
At work developing transformative biomedical-polymer products, Interface Biologics, a private company, has recently completed a $7M series B financing led by Business Development Bank of Canada in conjunction with Covington Capital and VG Partners.
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
Copyright © 2024 | WordPress Theme by MH Themes